| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | fluticasone furoate (Avamys®) |
| Formulation | 27.5 micrograms/spray nasal spray |
| Reference number | 372 |
| Indication | Treatment of the symptoms of allergic rhinitis in adults, adolescents (12 years and over) and children (6-11 years) |
| Company | GlaxoSmithKline |
| BNF chapter | Ear, nose & oropharynx |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/11/2008 |